Minyan Mailbag and the Important Stuff
Sending prayers and white light...
Minyanville is a creative education community predicated on the financial markets. What makes us unique, however, is that we share a benevolence that transcends the flickering ticks and whippy trips.
I received an email yesterday from a close friend and wanted to share it with ye faithful. While I know we're in the middle of earnings season, I will humbly ask each of you to take five minutes for a most worthy cause. It'll mean more than you know.
As you know, my wife has been diagnosed with pancreatic cancer. Fortunately, through an aggressive program of chemotherapy, relying heavily on the new Imclone drug Erbitux, she has seen some promising results, including the shrinkage of her tumors by as much as thirty percent. Unfortunately, because Erbitux has only been approved by the FDA for colon cancer, Blue Cross will not pay a penny of the $100,000 annual cost of this treatment.
There is ample evidence that Erbitux will prolong the life of most pancreatic cancer patients, but few can shoulder this enormous expense. So I am asking you to log into this site and add your name (and the names of each member of your family) to this petition in order to make this life saving drug available to the people who so desperately need it. And if you could forward this email to your friends I would be enormously grateful.
Todd Harrison is the founder and Chief Executive Officer of Minyanville. Prior to his current role, Mr. Harrison was President and head trader at a $400 million dollar New York-based hedge fund. Todd welcomes your comments and/or feedback at firstname.lastname@example.org.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Daily Recap Newsletter